Back to Search
Start Over
Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes.
- Source :
-
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2006 Oct; Vol. 34 (10), pp. 1756-63. Date of Electronic Publication: 2006 Jul 12. - Publication Year :
- 2006
-
Abstract
- Sinusoidal and canalicular hepatic drug transporters constitute key factors involved in drug elimination from liver. Regulation of their expression via activation of xenosensors, such as aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), pregnane X receptor (PXR), and nuclear factor E2-related factor 2 (Nrf2), remains incompletely characterized. The present study was therefore designed to carefully analyze expression of major drug transporters in primary human hepatocytes exposed to dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD) (an AhR activator), rifampicin (RIF) (a PXR activator), phenobarbital (PB) (a CAR activator), and oltipraz (OPZ) (a Nrf2 activator), using mainly reverse transcription-real time polymerase chain reaction assays. With a threshold corresponding to a 1.5-fold factor change in mRNA levels, observed in at least three of seven independent human hepatocyte cultures, efflux transporters such as MDR1, MRP2 and BCRP were up-regulated by PB, RIF, and OPZ, whereas MRP3 was induced by OPZ and RIF. MDR1 and BCRP expression was also increased by TCDD- and RIF-augmented mRNA levels of the influx transporter OATP-C. Bile acid transporters, i.e., bile salt export pump and Na(+)-taurocholate cotransporting polypeptide, and the sinusoidal transporter, OAT2, were down-regulated by all the tested chemicals. Influx transporters such as OCT1, OATP-B, and OATP8 were repressed by PB and TCDD. PB also decreased MRP6 expression, whereas mRNA levels of OCT1 and OATP8 were down-regulated by RIF and OPZ, respectively. Taken together, these data establish a complex pattern of transporter regulation by xenobiotics in human hepatocytes, in addition to interindividual variability in responsiveness. This may deserve further attention with respect to drug-drug interactions and adverse effects of hepatic drugs.
- Subjects :
- ATP Binding Cassette Transporter, Subfamily B, Member 1 genetics
ATP Binding Cassette Transporter, Subfamily G, Member 2
Adult
Constitutive Androstane Receptor
Hepatocytes cytology
Hepatocytes metabolism
Humans
Membrane Transport Proteins genetics
Multidrug Resistance-Associated Protein 2
Multidrug Resistance-Associated Proteins genetics
NF-E2-Related Factor 2 genetics
Neoplasm Proteins genetics
Phenobarbital pharmacology
Polychlorinated Dibenzodioxins pharmacology
Pregnane X Receptor
Pyrazines pharmacology
RNA, Messenger genetics
RNA, Messenger metabolism
Receptors, Aryl Hydrocarbon drug effects
Receptors, Aryl Hydrocarbon metabolism
Receptors, Cytoplasmic and Nuclear genetics
Receptors, Steroid genetics
Reverse Transcriptase Polymerase Chain Reaction methods
Rifampin pharmacology
Symporters genetics
Thiones
Thiophenes
Transcription Factors genetics
ATP-Binding Cassette Transporters genetics
Gene Expression Regulation drug effects
Hepatocytes drug effects
Receptors, Drug genetics
Xenobiotics pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 0090-9556
- Volume :
- 34
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Drug metabolism and disposition: the biological fate of chemicals
- Publication Type :
- Academic Journal
- Accession number :
- 16837569
- Full Text :
- https://doi.org/10.1124/dmd.106.010033